참고문헌
- Barr, M.P., Gray, S.G., Hoffmann, A.C., Hilger, R.A., Thomale, J., O’Flaherty, J.D., Fennell, D.A., Richard, D., O’Leary, J.J., and O’Byrne, K.J. (2013). Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS One 8, e54193. https://doi.org/10.1371/journal.pone.0054193
- Bui-Nguyen, T.M., Pakala, S.B., Sirigiri, R.D., Xia, W., Hung, M.C., Sarin, S.K., Kumar, V., Slagle, B.L., and Kumar, R. (2010). NFkappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene 29, 1179-1189. https://doi.org/10.1038/onc.2009.404
- Donnenberg, V.S., and Donnenberg, A.D. (2005). Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J.Clin.Pharmacol. 45, 872-877. https://doi.org/10.1177/0091270005276905
- Godwin, P., Baird, A.M., Heavey, S., Barr, M.P., O'Byrne, K.J., and Gately, K. (2013). Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Front.Oncol. 3, 120.
- Kumar, R., Wang, R.A., and Bagheri-Yarmand, R. (2003). Emerging roles of MTA family members in human cancers. Semi.Oncol. 30, 30-37. https://doi.org/10.1053/sonc.2003.37273
- Kumar, R., Balasenthil, S., Pakala, S.B., Rayala, S.K., Sahin, A.A., and Ohshiro, K. (2010). Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells. Cancer Res. 70, 6598-6608. https://doi.org/10.1158/0008-5472.CAN-10-0907
- Li, D.Q., Pakala, S.B., Nair, S.S., Eswaran, J., and Kumar, R. (2012a). Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res. 72, 387-394. https://doi.org/10.1158/0008-5472.CAN-11-2345
- Li, Y., Huang, W., Huang, S., Du, J., and Huang, C. (2012b). Screening of anti-cancer agent using zebrafish: comparison with the MTT assay. Biochem.Biophys.Res.Commun. 422, 85-90. https://doi.org/10.1016/j.bbrc.2012.04.110
- Liu, A.Y., Cai, Y., Mao, Y., Lin, Y., Zheng, H., Wu, T., Huang, Y., Fang, X., Lin, S., Feng, Q., et al. (2014). Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. Carcinogenesis 35, 537-545. https://doi.org/10.1093/carcin/bgt364
- Ma, B.B., Lui, V.W., Hui, E.P., Lau, C.P., Ho, K., Ng, M.H., Cheng, S.H., Tsao, S.W., and Chan, A.T. (2010). The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines. Invest. New Drugs 28, 413-420. https://doi.org/10.1007/s10637-009-9269-x
- Ma, L., Zhang, G., Miao, X.B., Deng, X.B., Wu, Y., Liu, Y., Jin, Z.R., Li, X.Q., Liu, Q.Z., Sun, D.X., et al. (2013). Cancer stem-like cell properties are regulated by EGFR/AKT/beta-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma. FEBS J. 280, 2027-2041. https://doi.org/10.1111/febs.12226
- Morais, C., Gobe, G., Johnson, D.W., and Healy, H. (2010). Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma. Apoptosis 15, 412-425. https://doi.org/10.1007/s10495-009-0414-y
- Nagaraj, S.R., Shilpa, P., Rachaiah, K., and Salimath, B.P. (2013). Crosstalk between VEGF and MTA1 signaling pathways contrib-ute to aggressiveness of breast carcinoma. Mol. Carcinog. [Epub ahead of print].
- Reddy, S.D., Pakala, S.B., Molli, P.R., Sahni, N., Karanam, N.K., Mudvari, P., and Kumar, R. (2012). Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function. J. Biol.Chem. 287, 27843-27850. https://doi.org/10.1074/jbc.M112.348474
- Salot, S., and Gude, R. (2013). MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines. Eur. J.Cancer 49, 492-499. https://doi.org/10.1016/j.ejca.2012.06.019
- Serin, M., Erkal, H.S., and Cakmak, A. (1999). Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas. Acta Oncol. 38, 1031-1035. https://doi.org/10.1080/028418699432310
- Shafee, N., Smith, C.R., Wei, S., Kim, Y., Mills, G.B., Hortobagyi, G.N., Stanbridge, E.J., and Lee, E.Y. (2008). Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Res. 68, 3243-3250. https://doi.org/10.1158/0008-5472.CAN-07-5480
- Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., and Dirks, P.B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828.
- Song, Q., Zhang, H., Wang, M., Song, W., Ying, M., Fang, Y., Li, Y., Chao, Y., and Zhu, X. (2013). MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo. J.Exp.Clin.Cancer Res. 32, 54. https://doi.org/10.1186/1756-9966-32-54
- Spano, J.P., Busson, P., Atlan, D., Bourhis, J., Pignon, J.P., Esteban, C., and Armand, J.P. (2003). Nasopharyngeal carcinomas: an update. Eur. J.Pharmacol. 39, 2121-2135.
- Venkatesha, V.A., Parsels, L.A., Parsels, J.D., Zhao, L., Zabludoff, S.D., Simeone, D.M., Maybaum, J., Lawrence, T.S., and Morgan, M.A. (2012). Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. Neoplasia 14, 519-525. https://doi.org/10.1593/neo.12538
- Vinogradov, S., and Wei, X. (2012). Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine 7, 597-615. https://doi.org/10.2217/nnm.12.22
- Wang, H., Zhang, G., Zhang, H., Zhang, F., Zhou, B., Ning, F., Wang, H.S., Cai, S.H., and Du, J. (2014). Acquisition of epithelialmesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/beta-catenin/Snail signaling pathway. Eur. J. Pharmacol. 723, 156-166. https://doi.org/10.1016/j.ejphar.2013.12.004
- Zhang, Y., Ng, H.H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. (1999). Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935. https://doi.org/10.1101/gad.13.15.1924
피인용 문헌
- Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells vol.36, pp.37, 2017, https://doi.org/10.1038/onc.2017.19
- Implications of cancer stem cells in developing therapeutic resistance in oral cancer vol.62, 2016, https://doi.org/10.1016/j.oraloncology.2016.10.008
- MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma vol.39, pp.6, 2017, https://doi.org/10.1177/1010428317703825
- Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy vol.18, pp.7, 2017, https://doi.org/10.3390/ijms18071506
- Epigenomic regulation of oncogenesis by chromatin remodeling vol.35, pp.34, 2016, https://doi.org/10.1038/onc.2015.513
- HLA-A2-Restricted Epitopes Identified from MTA1 Could Elicit Antigen-Specific Cytotoxic T Lymphocyte Response vol.2018, pp.2314-7156, 2018, https://doi.org/10.1155/2018/2942679
- High NEK2 confers to poor prognosis and contributes to cisplatin-based chemotherapy resistance in nasopharyngeal carcinoma pp.07302312, 2018, https://doi.org/10.1002/jcb.27632
- MTA1 promotes viability and motility in nasopharyngeal carcinoma by modulating IQGAP1 expression vol.119, pp.5, 2018, https://doi.org/10.1002/jcb.26494
- MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity vol.10, pp.3, 2019, https://doi.org/10.1038/s41419-019-1424-5
- Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma vol.9, pp.None, 2014, https://doi.org/10.2147/ott.s96518